Tag: Hims & Hers

The U.S. Food and Drug Administration (FDA) has launched a significant regulatory action, placing telehealth company Hims & Hers under ...

The telehealth company Hims & Hers is embarking on a significant strategic shift, moving its focus toward men's hormone therapies. ...

The telehealth provider Hims & Hers finds itself navigating turbulent regulatory waters. Its recent expansion into the multi-billion dollar testosterone ...

Telehealth provider Hims & Hers Health is making a bold strategic move to capture a significant share of the lucrative ...

Telehealth innovator Hims & Hers Health is pursuing a significant expansion opportunity that could unlock substantial new revenue streams. Rather ...

While telemedicine provider Hims & Hers Health continues to demonstrate impressive user acquisition and revenue expansion, recent actions by its ...

The telehealth provider Hims & Hers appears to be staging a significant recovery after months of facing skepticism from market ...

A landmark court decision has removed the most significant legal threat facing the rapidly expanding market for affordable weight-loss medications. ...

The fundamental legality of its business model has emerged as an existential threat to telehealth provider Hims & Hers. An ...

Telehealth provider Hims & Hers Health, Inc. faces a critical juncture as the August 25, 2025, deadline passes for shareholders ...